Animal and cellular models of chronic pain

Advanced Drug Delivery Reviews

Volumn 55, Issue 8, 2003, Pages 949-965

  Wang, Lili X ^a   Wang, Zaijie Jim ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Allodynia; Cancer; Hyperalgesia; Nerve injury; Neuropathy; Sensory neurons

Indexed keywords

ANIMAL CELL CULTURE; BONE; DRUG DOSAGE; TUMORS;

CHRONIC PAIN;

HEALTH HAZARDS;

CELECOXIB; CISPLATIN; CYCLOOXYGENASE 2 INHIBITOR; OPIATE; PACLITAXEL; PAMIDRONIC ACID; VINCRISTINE; ZOLEDRONIC ACID;

ACUTE LEUKEMIA; ALLODYNIA; CANCER PAIN; CANCER RADIOTHERAPY; CELL CULTURE; CHRONIC PAIN; DNA MICROARRAY; DRUG EFFECT; DRUG MECHANISM; GENOMICS; HODGKIN DISEASE; HYPERALGESIA; KAPOSI SARCOMA; LIGATION; LONG TERM CARE; MOLECULAR MECHANICS; NERVE LIGATION; NEURITIS; NEUROBLASTOMA; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; NONHUMAN; PARESTHESIA; PERIPHERAL NEUROPATHY; PHOTOCHEMISTRY; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SKIN TINGLING; SPINAL CORD INJURY; SPINAL NERVE;

EID: 0142043867     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(03)00098-X     Document Type: Article

References (216)

1. Levitt M., Levitt J.H. The deafferentation syndrome in monkeys: dysesthesias of spinal origin. Pain. 10:1981;129-147.
2. Kirk E.J., Denny-Brown D. Functional variation in dermatomes in the macaque monkey following dorsal root lesions. J. Comp. Neurol. 139:1970;307-320.
3. Carlton S.M., Lekan H.A., Kim S.H., Chung J.M. Behavioral manifestations of an experimental model for peripheral neuropathy produced by spinal nerve ligation in the primate. Pain. 56:1994;155-166.
4. Ford R.W. A reproducible spinal cord injury model in the cat. J. Neurosurg. 59:1983;268-275.
5. Hylden J.L., Ruda M.A., Hayashi H., Dubner R. Descending serotonergic fibers in the dorsolateral and ventral funiculi of cat spinal cord. Neurosci. Lett. 62:1985;299-304.
6. Yezierski R.P., Schwartz R.H. Response and receptive-field properties of spinomesencephalic tract cells in the cat. J. Neurophysiol. 55:1986;76-96.
7. Ogawa T., Mimura Y., Kato H., Ootsubo S., Murakoshi M. The usefulness of rabbits as an animal model for the neuropathological assessment of neurotoxicity following the administration of vincristine. Neurotoxicology. 21:2000;501-511.
8. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 353:1999;1959-1964.
9. Zimmermann M. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 429:2001;23-37.
10. Dubner R. Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury. Bond M.R., Charlton J.E., Woolf C.J. Proceedings of the VIth World Congress on Pain. 1991;263-276 Elsevier, Amsterdam.
11. Woolf C.J. Windup and central sensitization are not equivalent. Pain. 66:1996;105-108.
12. Mitchell S.W. Injuries of Nerves and Their Consequence. 1872;J.B. Lippincott, Philadelphia, PA.
13. Markus H., Pomeranz B., Krushelnycky D. Spread of saphenous somatotopic projection map in spinal cord and hypersensitivity of the foot after chronic sciatic denervation in adult rat. Brain Res. 296:1984;27-39.
14. Vallin J.A., Kingery W.S. Adjacent neuropathic hyperalgesia in rats: a model for sympathetic independent pain. Neurosci. Lett. 133:1991;241-244.
15. Lee B.H., Won R., Baik E.J., Lee S.H., Moon C.H. An animal model of neuropathic pain employing injury to the sciatic nerve branches. Neuroreport. 11:2000;657-661.
16. Kawakami M., Weinstein J.N., Chatani K., Spratt K.F., Meller S.T., Gebhart G.F. Experimental lumbar radiculopathy. Behavioral and histologic changes in a model of radicular pain after spinal nerve root irritation with chromic gut ligatures in the rat. Spine. 19:1994;1795-1802.
17. Lombard M.C., Nashold B.S. Jr., Albe-Fessard D., Salman N., Sakr C. Deafferentation hypersensitivity in the rat after dorsal rhizotomy: a possible animal model of chronic pain. Pain. 6:1979;163-174.
18. Brinkhus H.B., Zimmermann M. Characteristics of spinal dorsal horn neurons after partial chronic deafferentation by dorsal root transection. Pain. 15:1983;221-236.
19. Bennett G.J. Neuropathic pain: new insights, new interventions. Hosp. Pract. (Off. Ed.). 33:1998;95-98. also see pp. 101-104, 107-110.
20. Wall P.D., Devor M., Inbal R., Scadding J.W., Schonfeld D., Seltzer Z., Tomkiewicz M.M. Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa. Pain. 7:1979;103-111.
21. DeLeo J.A., Coombs D.W., Willenbring S., Colburn R.W., Fromm C., Wagner R., Twitchell B.B. Characterization of a neuropathic pain model: sciatic cryoneurolysis in the rat. Pain. 56:1994;9-16.
22. Kauppila T., Kontinen V.K., Pertovaara A. Weight bearing of the limb as a confounding factor in assessment of mechanical allodynia in the rat. Pain. 74:1998;55-59.
23. Mills C.D., Grady J.J., Hulsebosch C.E. Changes in exploratory behavior as a measure of chronic central pain following spinal cord injury. J. Neurotrauma. 18:2001;1091-1105.
24. Beric A., Dimitrijevic M.R., Lindblom U. Central dysesthesia syndrome in spinal cord injury patients. Pain. 34:1988;109-116.
25. Cohen M.J., Song Z.K., Schandler S.L., Ho W.H., Vulpe M. Sensory detection and pain thresholds in spinal cord injury patients with and without dysesthetic pain, and in chronic low back pain patients. Somatosens. Motor Res. 13:1996;29-37.
26. Cohen M.J., McArthur D.L., Vulpe M., Schandler S.L., Gerber K.E. Comparing chronic pain from spinal cord injury to chronic pain of other origins. Pain. 35:1988;57-63.
27. Yezierski R.P. Pain following spinal cord injury: the clinical problem and experimental studies. Pain. 68:1996;185-194.
28. Allen A.R. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. J. Am. Med. Assoc. 57:1911;878-880.
29. Tator C.H. Experimental circumferential compression injury of primate spinal cord. Proc. Veterans Adm. Spinal Cord Inj. Conf. 18:1971;2-5.
30. Tarlov I.M. Acute spinal cord compression paralysis. J. Neurosurg. 36:1972;10-20.
31. Tator C.H. Acute spinal cord injury in primates produced by an inflatable extradural cuff. Can. J. Surg. 16:1973;222-231.
32. Bjorklund A., Katzman R., Stenevi U., West K.A. Development and growth of axonal sprouts from noradrenaline and 5-hydroxytryptamine neurones in the rat spinal cord. Brain Res. 31:1971;21-33.
33. Rivlin A.S., Tator C.H. Regional spinal cord blood flow in rats after severe cord trauma. J. Neurosurg. 49:1978;844-853.
34. Rivlin A.S., Tator C.H. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg. Neurol. 10:1978;38-43.
35. Christensen M.D., Everhart A.W., Pickelman J.T., Hulsebosch C.E. Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain. 68:1996;97-107.
36. Bennett A.D., Everhart A.W., Hulsebosch C.E. Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury. Brain Res. 859:2000;72-82.
37. Bennett A.D., Chastain K.M., Hulsebosch C.E. Alleviation of mechanical and thermal allodynia by CGRP(8-37) in a rodent model of chronic central pain. Pain. 86:2000;163-175.
38. Christensen M.D., Hulsebosch C.E. Chronic central pain after spinal cord injury. J. Neurotrauma. 14:1997;517-537.
39. Hulsebosch C.E., Coggeshall R.E. Quantitation of sprouting of dorsal root axons. Science. 213:1981;1020-1021.
40. Balentine J.D. Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab. Invest. 39:1978;236-253.
41. Greenberg J., McKeever P.E., Balentine J.D. Lysosomal activity in experimental spinal cord trauma: an ultrastructural cytochemical evaluation. Surg. Neurol. 9:1978;361-364.
42. Anderson T.E. A controlled pneumatic technique for experimental spinal cord contusion. J. Neurosci. Methods. 6:1982;327-333.
43. Watson B.D., Prado R., Dietrich W.D., Ginsberg M.D., Green B.A. Photochemically induced spinal cord injury in the rat. Brain Res. 367:1986;296-300.
44. Prado R., Dietrich W.D., Watson B.D., Ginsberg M.D., Green B.A. Photochemically induced graded spinal cord infarction. Behavioral, electrophysiological, and morphological correlates. J. Neurosurg. 67:1987;745-753.
45. Hao J.X., Xu X.J., Aldskogius H., Seiger A., Wiesenfeld-Hallin Z. Allodynia-like effects in rat after ischaemic spinal cord injury photochemically induced by laser irradiation. Pain. 45:1991;175-185.
46. Xu X.J., Hao J.X., Aldskogius H., Seiger A., Wiesenfeld-Hallin Z. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain. 48:1992;279-290.
47. Hao J.X., Xu X.J., Aldskogius H., Seiger A., Wiesenfeld-Hallin Z. Photochemically induced transient spinal ischemia induces behavioral hypersensitivity to mechanical and cold stimuli, but not to noxious-heat stimuli, in the rat. Exp. Neurol. 118:1992;187-194.
48. Marsala M., Sorkin L.S., Yaksh T.L. Transient spinal ischemia in rat: characterization of spinal cord blood flow, extracellular amino acid release, and concurrent histopathological damage. J. Cereb. Blood Flow Metab. 14:1994;604-614.
49. Yezierski R.P., Park S.H. The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat. Neurosci. Lett. 157:1993;115-119.
50. Yezierski R.P., Santana M., Park S.H., Madsen P.W. Neuronal degeneration and spinal cavitation following intraspinal injections of quisqualic acid in the rat. J. Neurotrauma. 10:1993;445-456.
51. Yezierski R.P., Liu S., Ruenes G.L., Kajander K.J., Brewer K.L. Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model. Pain. 75:1998;141-155.
52. Yezierski R.P. Pain following spinal cord injury: pathophysiology and central mechanisms. Prog. Brain Res. 129:2000;429-449.
53. Abraham K.E., McGinty J.F., Brewer K.L. Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury. Pain. 90:2001;181-190.
54. Fairbanks C.A., Schreiber K.L., Brewer K.L., Yu C.G., Stone L.S., Kitto K.F., Nguyen H.O., Grocholski B.M., Shoeman D.W., Kehl L.J., Regunathan S., Reis D.J., Yezierski R.P., Wilcox G.L. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc. Natl. Acad. Sci. USA. 97:2000;10584-10589.
55. Wilcox G.L. Pharmacological studies of grooming and scratching behavior elicited by spinal substance P and excitatory amino acids. Ann. NY Acad. Sci. 525:1988;228-236.
56. Aanonsen L.M., Wilcox G.L. Muscimol, gamma-aminobutyric acid A receptors and excitatory amino acids in the mouse spinal cord. J. Pharmacol. Exp. Ther. 248:1989;1034-1038.
57. Sun X.F., Larson A.A. Behavioral sensitization to kainic acid and quisqualic acid in mice: comparison to NMDA and substance P responses. J. Neurosci. 11:1991;3111-3123.
58. Budai D., Wilcox G.L., Larson A.A. Enhancement of NMDA-evoked neuronal activity by glycine in the rat spinal cord in vivo. Neurosci. Lett. 135:1992;265-268.
59. Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., Malan T.P. Jr., Porreca F. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain. 68:1996;275-281.
60. Laughlin T.M., Vanderah T.W., Lashbrook J., Nichols M.L., Ossipov M., Porreca F., Wilcox G.L. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain. 72:1997;253-260.
61. Larson A.A., Wilcox G.L. Synergistic behavioral effects of serotonin and tryptamine injected intrathecally in mice. Neuropharmacology. 23:1984;1415-1418.
62. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
63. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
64. Devor M., Schonfeld D., Seltzer Z., Wall P.D. Two modes of cutaneous reinnervation following peripheral nerve injury. J. Comp. Neurol. 185:1979;211-220.
65. Decosterd I., Allchorne A., Woolf C.J. Progressive tactile hypersensitivity after a peripheral nerve crush: non-noxious mechanical stimulus-induced neuropathic pain. Pain. 100:2002;155-162.
66. DeLeo J.A., Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain. 90:2001;1-6.
67. Shimoyama M., Tanaka K., Hasue F., Shimoyama N. A mouse model of neuropathic cancer pain. Pain. 99:2002;167-174.
68. Fried K., Govrin-Lippmann R., Rosenthal F., Ellisman M.H., Devor M. Ultrastructure of afferent axon endings in a neuroma. J. Neurocytol. 20:1991;682-701.
69. Devor M., Wall P.D. Type of sensory nerve fibre sprouting to form a neuroma. Nature. 262:1976;705-708.
70. Amir R., Devor M. Ongoing activity in neuroma afferents bearing retrograde sprouts. Brain Res. 630:1993;283-288.
71. Seltzer Z., Paran Y., Eisen A., Ginzburg R. Neuropathic pain behavior in rats depends on the afferent input from nerve-end neuroma including histamine-sensitive C-fibers. Neurosci. Lett. 128:1991;203-206.
72. Saade N.E., Ibrahim M.Z., Atweh S.F., Jabbur S.J. Explosive autotomy induced by simultaneous dorsal column lesion and limb denervation: a possible model for acute deafferentation pain. Exp. Neurol. 119:1993;272-279.
73. Rodin B.E., Kruger L. Deafferentation in animals as a model for the study of pain: an alternative hypothesis. Brain Res. 319:1984;213-228.
74. Coderre T.J., Grimes R.W., Melzack R. Deafferentation and chronic pain in animals: an evaluation of evidence suggesting autotomy is related to pain. Pain. 26:1986;61-84.
75. Coderre T.J., Melzack R. Procedures which increase acute pain sensitivity also increase autotomy. Exp. Neurol. 92:1986;713-722.
76. Kauppila T. Correlation between autotomy-behavior and current theories of neuropathic pain. Neurosci. Biobehav. Rev. 23:1998;111-129.
77. Zeltser R., Beilin B., Zaslansky R., Seltzer Z. Comparison of autotomy behavior induced in rats by various clinically-used neurectomy methods. Pain. 89:2000;19-24.
78. Blumenkopf B., Lipman J.J. Studies in autotomy: its pathophysiology and usefulness as a model of chronic pain. Pain. 45:1991;203-209.
79. Riopelle J.M. The ethics of using animal models to study treatment of phantom pain. Anesthesiology. 76:1992;1069-1071.
80. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
81. Attal N., Jazat F., Kayser V., Guilbaud G. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain. 41:1990;235-251.
82. Choi Y., Yoon Y.W., Na H.S., Kim S.H., Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain. 59:1994;369-376.
83. Lee B.H., Yoon Y.W., Chung K., Chung J.M. Comparison of sympathetic sprouting in sensory ganglia in three animal models of neuropathic pain. Exp. Brain Res. 120:1998;432-438.
84. Kim K.J., Yoon Y.W., Chung J.M. Comparison of three rodent neuropathic pain models. Exp. Brain Res. 113:1997;200-206.
85. Malmberg A.B., Basbaum A.I. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain. 76:1998;215-222.
86. Sommer C., Schafers M. Painful mononeuropathy in C57BL/Wld mice with delayed Wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res. 784:1998;154-162.
87. Wang Z., Gardell L.R., Ossipov M.H., Vanderah T.W., Brennan M.B., Hochgeschwender U., Hruby V.J., Malan T.P. Jr., Lai J., Porreca F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J. Neurosci. 21:2001;1779-1786.
88. Wagner R., DeLeo J.A., Coombs D.W., Willenbring S., Fromm C. Spinal dynorphin immunoreactivity increases bilaterally in a neuropathic pain model. Brain Res. 629:1993;323-326.
89. Colburn R.W., Rickman A.J., DeLeo J.A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp. Neurol. 157:1999;289-304.
90. Willenbring S., Beauprie I.G., DeLeo J.A. Sciatic cryoneurolysis in rats: a model of sympathetically independent pain. Part 1: Effects of sympathectomy. Anesth. Analg. 81:1995;544-548.
91. Willenbring S., DeLeo J.A., Coombs D.W. Sciatic cryoneurolysis in rats: a model of sympathetically independent pain. Part 2: Adrenergic pharmacology. Anesth. Analg. 81:1995;549-554.
92. Na H.S., Han J.S., Ko K.H., Hong S.K. A behavioral model for peripheral neuropathy produced in rat's tail by inferior caudal trunk injury. Neurosci. Lett. 177:1994;50-52.
93. Back S.K., Sung B., Hong S.K., Na H.S. A mouse model for peripheral neuropathy produced by a partial injury of the nerve supplying the tail. Neurosci. Lett. 322:2002;153-156.
94. Bourque C.N., Anderson B.A., Martin del Campo C., Sima A.A. Sensorimotor perineuritis - an autoimmune disease? Can. J. Neurol. Sci. 12:1985;129-133.
95. Said G., Hontebeyrie-Joskowicz M. Nerve lesions induced by macrophage activation. Res. Immunol. 143:1992;589-599.
96. Chacur M., Milligan E.D., Gazda L.S., Armstrong C., Wang H., Tracey K.J., Maier S.F., Watkins L.R. A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain. 94:2001;231-244.
97. Gazda L.S., Milligan E.D., Hansen M.K., Twining C.M., Poulos N.M., Chacur M., O'Connor K.A., Armstrong C., Maier S.F., Watkins L.R., Myers R.R. Sciatic inflammatory neuritis (SIN): behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide production. J. Peripher. Nerv. Syst. 6:2001;111-129.
98. Maves T.J., Pechman P.S., Gebhart G.F., Meller S.T. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain. 54:1993;57-69.
99. Eliav E., Herzberg U., Ruda M.A., Bennett G.J. Neuropathic pain from an experimental neuritis of the rat sciatic nerve. Pain. 83:1999;169-182.
100. Simmons Z., Feldman E.L. Update on diabetic neuropathy. Curr. Opin. Neurol. 15:2002;595-603.
101. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M., Wilson D.M., O'Brien P.C., Melton L.J. 3rd, Service F.J. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 43:1993;817-824.
102. Rowbotham M.C., Yosipovitch G., Connolly M.K., Finlay D., Forde G., Fields H.L. Cutaneous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol. Dis. 3:1996;205-214.
103. Rowbotham M.C., Fields H.L. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain. 119:1996;347-354.
104. Sadzot-Delvaux C., Merville-Louis M.P., Delree P., Marc P., Piette J., Moonen G., Rentier B. An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J. Neurosci. Res. 26:1990;83-89.
105. Sadzot-Delvaux C., Debrus S., Nikkels A., Piette J., Rentier B. Varicella-zoster virus latency in the adult rat is a useful model for human latent infection. Neurology. 45:1995;S18-20.
106. Fleetwood-Walker S.M., Quinn J.P., Wallace C., Blackburn-Munro G., Kelly B.G., Fiskerstrand C.E., Nash A.A., Dalziel R.G. Behavioural changes in the rat following infection with varicella-zoster virus. J. Gen. Virol. 80:1999;2433-2436.
107. Bourdon-Wouters C., Merville-Louis M.P., Sadzot-Delvaux C., Marc P., Piette J., Delree P., Moonen G., Rentier B. Acute and persistent varicella-zoster virus infection of human and murine neuroblastoma cell lines. J. Neurosci. Res. 26:1990;90-97.
108. Kress M., Fickenscher H. Infection by human varicella-zoster virus confers norepinephrine sensitivity to sensory neurons from rat dorsal root ganglia. FASEB J. 15:2001;1037-1043.
109. Sadzot-Delvaux C., Thonard P., Schoonbroodt S., Piette J., Rentier B. Varicella-zoster virus induces apoptosis in cell culture. J. Gen. Virol. 76:1995;2875-2879.
110. Sima A.A. Peripheral neuropathy in the spontaneously diabetic BB-Wistar-rat. An ultrastructural study. Acta Neuropathol. 51:1980;223-227.
111. Mosseri R., Waner T., Shefi M., Shafrir E., Meyerovitch J. Gluconeogenesis in non-obese diabetic (NOD) mice: in vivo effects of vandadate treatment on hepatic glucose-6-phosphatase and phosphoenolpyruvate carboxykinase. Metabolism. 49:2000;321-325.
112. Pieper G.M., Mizoguchi H., Ohsawa M., Kamei J., Nagase H., Tseng L.F. Decreased opioid-induced antinociception but unaltered G-protein activation in the genetic-diabetic NOD mouse. Eur. J. Pharmacol. 401:2000;375-379.
113. Meyerovitch J., Rothenberg P., Shechter Y., Bonner-Weir S., Kahn C.R. Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. J. Clin. Invest. 87:1991;1286-1294.
114. Takeshita N., Yamaguchi I. Antinociceptive effects of morphine were different between experimental and genetic diabetes. Pharmacol. Biochem. Behav. 60:1998;889-897.
115. Kamei J., Sodeyama M., Ohsawa M., Kimura M., Tanaka S. Modulation by serum glucose levels on morphine-induced antinociceptive effect in C57BL/KsJ-db/db mice. Life Sci. 62:1998;L1-6.
116. Vincent A.L., Rodrick G.E., Sodeman W.A. Jr. The pathology of the Mongolian gerbil (Meriones unguiculatus): a review. Lab. Anim. Sci. 29:1979;645-651.
117. Shafrir E., Spielman S., Nachliel I., Khamaisi M., Bar-On H., Ziv E. Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil. Diabetes Metab. Res. Rev. 17:2001;55-66.
118. Lee J.H., Cox D.J., Mook D.G., McCarty R.C. Effect of hyperglycemia on pain threshold in alloxan-diabetic rats. Pain. 40:1990;105-107.
119. Courteix C., Bardin M., Chantelauze C., Lavarenne J., Eschalier A. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain. 57:1994;153-160.
120. Forman L.J., Estilow S., Lewis M., Vasilenko P. Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 weeks in female rats. Diabetes. 35:1986;1309-1313.
121. Wuarin-Bierman L., Zahnd G.R., Kaufmann F., Burcklen L., Adler J. Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy. Diabetologia. 30:1987;653-658.
122. Courteix C., Eschalier A., Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain. 53:1993;81-88.
123. Lesage P., Portenoy R.K. Trends in cancer pain management. Cancer Control. 6:1999;136-145.
124. Portenoy R.K., Lesage P. Management of cancer pain. Lancet. 353:1999;1695-1700.
125. Vecht C.J. Cancer pain: a neurological perspective. Curr. Opin. Neurol. 13:2000;649-653.
126. Aley K.O., Reichling D.B., Levine J.D. Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience. 73:1996;259-265.
127. Tanner K.D., Reichling D.B., Levine J.D. Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat. J. Neurosci. 18:1998;6480-6491.
128. Authier N., Coudore F., Eschalier A., Fialip J. Pain related behaviour during vincristine-induced neuropathy in rats. Neuroreport. 10:1999;965-968.
129. Nozaki-Taguchi N., Chaplan S.R., Higuera E.S., Ajakwe R.C., Yaksh T.L. Vincristine-induced allodynia in the rat. Pain. 93:2001;69-76.
130. Rowinsky E.K., Eisenhauer E.A., Chaudhry V., Arbuck S.G., Donehower R.C. Clinical toxicities encountered with paclitaxel (Taxol). Semin. Oncol. 20:1993;1-15.
131. Rowinsky E.K., Chaudhry V., Cornblath D.R., Donehower R.C. Neurotoxicity of Taxol. J. Natl. Cancer Inst. Monogr. 15:1993;107-115.
132. Socinski M.A. Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer. Oncologist. 4:1999;408-416.
133. Cavaletti G., Bogliun G., Marzorati L., Zincone A., Marzola M., Colombo N., Tredici G. Peripheral neurotoxicity of taxol in patients previously treated with cisplatin. Cancer. 75:1995;1141-1150.
134. Cavaletti G., Tredici G., Braga M., Tazzari S. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp. Neurol. 133:1995;64-72.
135. Mimura Y., Kato H., Eguchi K., Ogawa T. Schedule dependency of paclitaxel-induced neuropathy in mice: a morphological study. Neurotoxicology. 21:2000;513-520.
136. Wiernik P.H., Schwartz E.L., Einzig A., Strauman J.J., Lipton R.B., Dutcher J.P. Phase I trial of taxol given as a 24-h infusion every 21 days: responses observed in metastatic melanoma. J. Clin. Oncol. 5:1987;1232-1239.
137. Dina O.A., Chen X., Reichling D., Levine J.D. Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat. Neuroscience. 108:2001;507-515.
138. Polomano R.C., Mannes A.J., Clark U.S., Bennett G.J. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain. 94:2001;293-304.
139. Authier N., Gillet J.P., Fialip J., Eschalier A., Coudore F. Description of a short-term Taxol-induced nociceptive neuropathy in rats. Brain Res. 887:2000;239-249.
140. Boyle F.M., Wheeler H.R., Shenfield G.M. Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. J. Neurooncol. 41:1999;107-116.
141. Cliffer K.D., Siuciak J.A., Carson S.R., Radley H.E., Park J.S., Lewis D.R., Zlotchenko E., Nguyen T., Garcia K., Tonra J.R., Stambler N., Cedarbaum J.M., Bodine S.C., Lindsay R.M., DiStefano P.S. Physiological characterization of Taxol-induced large-fiber sensory neuropathy in the rat. Ann. Neurol. 43:1998;46-55.
142. Apfel S.C., Lipton R.B., Arezzo J.C., Kessler J.A. Nerve growth factor prevents toxic neuropathy in mice. Ann. Neurol. 29:1991;87-90.
143. Strumberg D., Brugge S., Korn M.W., Koeppen S., Ranft J., Scheiber G., Reiners C., Mockel C., Seeber S., Scheulen M.E. Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann. Oncol. 13:2002;229-236.
144. Fischer S.J., Podratz J.L., Windebank A.J. Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: studies in PC12 cells and p75 null mouse dorsal root ganglia. Neurosci. Lett. 308:2001;1-4.
145. McDonald E.S., Windebank A.J. Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling. Neurobiol. Dis. 9:2002;220-233.
146. Authier N., Fialip J., Eschalier A., Coudore F. Assessment of allodynia and hyperalgesia after cisplatin administration to rats. Neurosci. Lett. 291:2000;73-76.
147. De Koning P., Neijt J.P., Jennekens F.G., Gispen W.H. Evaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in rats. Toxicol. Appl. Pharmacol. 89:1987;81-87.
148. Verdu E., Vilches J.J., Rodriguez F.J., Ceballos D., Valero A., Navarro X. Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice. Muscle Nerve. 22:1999;329-340.
149. Pradat P.F., Kennel P., Naimi-Sadaoui S., Finiels F., Scherman D., Orsini C., Delaere P., Mallet J., Revah F. Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy. Gene Ther. 9:2002;1333-1337.
150. Tassler P., Dellon A.L., Lesser G.J., Grossman S. Utility of decompressive surgery in the prophylaxis and treatment of cisplatin neuropathy in adult rats. J. Reconstr. Microsurg. 16:2000;457-463.
151. ter Laak M.P., Hamers F.P., Kirk C.J., Gispen W.H. rhGGF2 protects against cisplatin-induced neuropathy in the rat. J. Neurosci. Res. 60:2000;237-244.
152. Verstappen C.C., Geldof A.A., Postma T.J., Heimans J.J. In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065. J. Neurooncol. 44:1999;1-5.
153. Hamers F.P., Pette C., Bravenboer B., Vecht C.J., Neijt J.P., Gispen W.H. Cisplatin-induced neuropathy in mature rats: effects of the melanocortin-derived peptide ORG 2766. Cancer Chemother. Pharmacol. 32:1993;162-166.
154. Gispen W.H., Hamers F.P., Vecht C.J., Jennekens F.G., Neyt J.P. ACTH/MSH like peptides in the treatment of cisplatin neuropathy. J. Steroid Biochem. Mol. Biol. 43:1992;179-183.
155. de Koning P., Neijt J.P., Jennekens F.G., Gispen W.H. Org.2766 protects from cisplatin-induced neurotoxicity in rats. Exp. Neurol. 97:1987;746-750.
156. Foley K.M. Controlling the pain of cancer. Sci. Am. 275:1996;164-165.
157. Martin L.A., Hagen N.A. Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. J. Pain Symptom Manage. 14:1997;99-117.
158. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 69:1997;1-18.
159. Coleman R.E., Rubens R.D. The clinical course of bone metastases from breast cancer. Br. J. Cancer. 55:1987;61-66.
160. Coleman R.E., Rubens R.D. Bone metastases and breast cancer. Cancer Treat. Rev. 12:1985;251-270.
161. Schwei M.J., Honore P., Rogers S.D., Salak-Johnson J.L., Finke M.P., Ramnaraine M.L., Clohisy D.R., Mantyh P.W. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J. Neurosci. 19:1999;10886-10897.
162. Honore P., Schwei J., Rogers S.D., Salak-Johnson J.L., Finke M.P., Ramnaraine M.L., Clohisy D.R., Mantyh P.W. Cellular and neurochemical remodeling of the spinal cord in bone cancer pain. Prog. Brain Res. 129:2000;389-397.
163. Honore P., Rogers S.D., Schwei M.J., Salak-Johnson J.L., Luger N.M., Sabino M.C., Clohisy D.R., Mantyh P.W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience. 98:2000;585-598.
164. Honore P., Luger N.M., Sabino M.A., Schwei M.J., Rogers S.D., Mach D.B., O'Keefe F.P., Ramnaraine M.L., Clohisy D.R., Mantyh P.W. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat. Med. 6:2000;521-528.
165. Luger N.M., Honore P., Sabino M.A., Schwei M.J., Rogers S.D., Mach D.B., Clohisy D.R., Mantyh P.W. Osteoprotegerin diminishes advanced bone cancer pain. Cancer Res. 61:2001;4038-4047.
166. Sabino M.A., Ghilardi J.R., Jongen J.L., Keyser C.P., Luger N.M., Mach D.B., Peters C.M., Rogers S.D., Schwei M.J., de Felipe C., Mantyh P.W. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res. 62:2002;7343-7349.
167. Luger N.M., Sabino M.A., Schwei M.J., Mach D.B., Pomonis J.D., Keyser C.P., Rathbun M., Clohisy D.R., Honore P., Yaksh T.L., Mantyh P.W. Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer versus inflammatory pain. Pain. 99:2002;397-406.
168. Mantyh P.W., Clohisy D.R., Koltzenburg M., Hunt S.P. Molecular mechanisms of cancer pain. Nat. Rev. Cancer. 2:2002;201-209.
169. Mantyh P.W. A mechanism based understanding of cancer pain. Pain. 96:2002;1-2.
170. Wacnik P.W., Eikmeier L.J., Ruggles T.R., Ramnaraine M.L., Walcheck B.K., Beitz A.J., Wilcox G.L. Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J. Neurosci. 21:2001;9355-9366.
171. Cain D.M., Wacnik P.W., Turner M., Wendelschafer-Crabb G., Kennedy W.R., Wilcox G.L., Simone D.A. Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J. Neurosci. 21:2001;9367-9376.
172. Walker K., Medhurst S.J., Kidd B.L., Glatt M., Bowes M., Patel S., McNair K., Kesingland A., Green J., Chan O., Fox A.J., Urban L.A. Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain. Pain. 100:2002;219-229.
173. Fulfaro F., Casuccio A., Ticozzi C., Ripamonti C. The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials. Pain. 78:1998;157-169.
174. Schultzberg M., Ebendal T., Hokfelt T., Nilsson G., Pfenninger K. Substance P-like immunoreactivity in cultured spinal ganglia from chick embryos. J. Neurocytol. 7:1978;107-117.
175. Baccaglini P.I., Hogan P.G. Some rat sensory neurons in culture express characteristics of differentiated pain sensory cells. Proc. Natl. Acad. Sci. USA. 80:1983;594-598.
176. Adler J.E., Kessler J.A., Black I.B. Development and regulation of substance P in sensory neurons in vitro. Dev. Biol. 102:1984;417-425.
177. Eckert S.P., Taddese A., McCleskey E.W. Isolation and culture of rat sensory neurons having distinct sensory modalities. J. Neurosci. Methods. 77:1997;183-190.
178. Vasko M.R., Campbell W.B., Waite K.J. Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J. Neurosci. 14:1994;4987-4997.
179. Hingtgen C.M., Vasko M.R. Prostacyclin enhances the evoked-release of substance P and calcitonin gene-related peptide from rat sensory neurons. Brain Res. 655:1994;51-60.
180. Southall M.D., Vasko M.R. Prostaglandin E(2)-mediated sensitization of rat sensory neurons is not altered by nerve growth factor. Neurosci. Lett. 287:2000;33-36.
181. Burgess G.M., Mullaney I., McNeill M., Dunn P.M., Rang H.P. Second messengers involved in the mechanism of action of bradykinin in sensory neurons in culture. J. Neurosci. 9:1989;3314-3325.
182. Basbaum A.I. Distinct neurochemical features of acute and persistent pain. Proc. Natl. Acad. Sci. USA. 96:1999;7739-7743.
183. Dodd J., Jessell T.M. Lactoseries carbohydrates specify subsets of dorsal root ganglion neurons projecting to the superficial dorsal horn of rat spinal cord. J. Neurosci. 5:1985;3278-3294.
184. Hingtgen C.M., Vasko M.R. The phosphatase inhibitor, okadaic acid, increases peptide release from rat sensory neurons in culture. Neurosci. Lett. 178:1994;135-138.
185. Barber L.A., Vasko M.R. Activation of protein kinase C augments peptide release from rat sensory neurons. J. Neurochem. 67:1996;72-80.
186. Evans A.R., Vasko M.R., Nicol G.D. The cAMP transduction cascade mediates the PGE2-induced inhibition of potassium currents in rat sensory neurones. J. Physiol. 516:1999;163-178.
187. Dymshitz J., Vasko M.R. Nitric oxide and cyclic guanosine 3′,5′-monophosphate do not alter neuropeptide release from rat sensory neurons grown in culture. Neuroscience. 62:1994;1279-1286.
188. 2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. Neuropharmacology. 42:2002;353-366.
189. Wood J.N., Coote P.R., Minhas A., Mullaney I., McNeill M., Burgess G.M. Capsaicin-induced ion fluxes increase cyclic GMP but not cyclic AMP levels in rat sensory neurones in culture. J. Neurochem. 53:1989;1203-1211.
190. Banerjee P., Berry-Kravis E., Bonafede-Chhabra D., Dawson G. Heterologous expression of the serotonin 5-HT1A receptor in neural and non-neural cell lines. Biochem. Biophys. Res. Commun. 192:1993;104-110.
191. Chaudhary P., Martenson M.E., Baumann T.K. Vanilloid receptor expression and capsaicin excitation of rat dental primary afferent neurons. J. Dent. Res. 80:2001;1518-1523.
192. Wood J.N., Winter J., James I.F., Rang H.P., Yeats J., Bevan S. Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture. J. Neurosci. 8:1988;3208-3220.
193. Chen J.J., Dymshitz J., Vasko M.R. Regulation of opioid receptors in rat sensory neurons in culture. Mol. Pharmacol. 51:1997;666-673.
194. Smith J.A., Amagasu S.M., Eglen R.M., Hunter J.C., Bley K.R. Characterization of prostanoid receptor-evoked responses in rat sensory neurones. Br. J. Pharmacol. 124:1998;513-523.
195. Perney T.M., Hirning L.D., Leeman S.E., Miller R.J. Multiple calcium channels mediate neurotransmitter release from peripheral neurons. Proc. Natl. Acad. Sci. USA. 83:1986;6656-6659.
196. Woolf C.J., Reynolds M.L., Molander C., O'Brien C., Lindsay R.M., Benowitz L.I. The growth-associated protein GAP-43 appears in dorsal root ganglion cells and in the dorsal horn of the rat spinal cord following peripheral nerve injury. Neuroscience. 34:1990;465-478.
197. Petersen M., Zhang J., Zhang J.M., LaMotte R.H. Abnormal spontaneous activity and responses to norepinephrine in dissociated dorsal root ganglion cells after chronic nerve constriction. Pain. 67:1996;391-397.
198. Platika D., Boulos M.H., Baizer L., Fishman M.C. Neuronal traits of clonal cell lines derived by fusion of dorsal root ganglia neurons with neuroblastoma cells. Proc. Natl. Acad. Sci. USA. 82:1985;3499-3503.
199. Platika D., Baizer L., Fishman M.C. Sensory neurons 'immortalized' by fusion with neuroblastoma cells. Trans. Assoc. Am. Physicians. 98:1985;301-304.
200. Wood J.N., Bevan S.J., Coote P.R., Dunn P.M., Harmar A., Hogan P., Latchman D.S., Morrison C., Rougon G., Theveniau M., et al. Novel cell lines display properties of nociceptive sensory neurons. Proc. R. Soc. Lond. B Biol. Sci. 241:1990;187-194.
201. Francel P.C., Harris K., Smith M., Fishman M.C., Dawson G., Miller R.J. Neurochemical characteristics of a novel dorsal root ganglion× neuroblastoma hybrid cell line, F-11. J. Neurochem. 48:1987;1624-1631.
202. Kusano K., Gainer H. Modulation of voltage-activated Ca currents by pain-inducing agents in a dorsal root ganglion neuronal line, F-11. J. Neurosci. Res. 34:1993;158-169.
203. Naruse K., McGehee D.S., Oxford G.S. Differential responses of Ca-activated K channels to bradykinin in sensory neurons and F-11 cells. Am. J. Physiol. 262:1992;C453-460.
204. + currents upon activation. Brain Res. 590:1992;329-333.
205. Singh J.K., Yan Q., Dawson G., Banerjee P. Cell-specific regulation of the stably expressed serotonin 5-HT1A receptor and altered ganglioside synthesis. Biochim. Biophys. Acta. 1310:1996;201-211.
206. Raymon H.K., Thode S., Zhou J., Friedman G.C., Pardinas J.R., Barrere C., Johnson R.M., Sah D.W. Immortalized human dorsal root ganglion cells differentiate into neurons with nociceptive properties. J. Neurosci. 19:1999;5420-5428.
207. Laird J.M., Souslova V., Wood J.N., Cervero F. Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. J. Neurosci. 22:2002;8352-8356.
208. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature. 306:1983;686-688.
209. Shir Y., Zeltser R., Vatine J.J., Carmi G., Belfer I., Zangen A., Overstreet D., Raber P., Seltzer Z. Correlation of intact sensibility and neuropathic pain-related behaviors in eight inbred and outbred rat strains and selection lines. Pain. 90:2001;75-82.
210. Mills C.D., Fullwood S.D., Hulsebosch C.E. Changes in metabotropic glutamate receptor expression following spinal cord injury. Exp. Neurol. 170:2001;244-257.
211. Aley K.O., Levine J.D. Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience. 111:2002;389-397.
212. Kim Y.I., Na H.S., Yoon Y.W., Nahm S.H., Ko K.H., Hong S.K. Mechanical allodynia is more strongly manifested in older rats in an experimental model of peripheral neuropathy. Neurosci. Lett. 199:1995;158-160.
213. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods. 53:1994;55-63.
214. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
215. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflammed tissue. Arch. Int. Pharmacodyn. 61:1957;409-419.
216. Quasthoff S., Hartung H.P. Chemotherapy-induced peripheral neuropathy. J. Neurol. 249:2002;9-17.